Vir Biotechnology's total assets for Q3 2024 were $1.50B, a decrease of -10.25% from the previous quarter. VIR total liabilities were $257.63M for the fiscal quarter, a 9.22% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.